Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma [Phase 1]
Phase 1 trial testing EBV-specific cytotoxic T cells in relapsed EBV-positive lymphomas has completed, assessing safety and preliminary acti…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma [Phase 3]
Phase 3 clinical trial update on managing pain and chemotherapy-related symptoms in people with multiple myeloma or lymphoma, with results p…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL [Phase 1]
Phase 1 trial evaluating haploidentical stem cell transplantation with prophylactic natural killer donor lymphocyte infusion in lymphoma, mu…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: MargheRITA (Remote Intelligence for Therapeutic Adherence) [NA]
A completed clinical trial named MargheRITA (Remote Intelligence for Therapeutic Adherence) sponsored by Advice Pharma Group srl studied tre…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Lung Screening in People Cured of Hodgkin Lymphoma [NA]
A completed clinical trial update evaluating lung cancer screening in individuals who have been cured of Hodgkin lymphoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial update on a Triplex CMV vaccine designed to prevent CMV infection in patients undergoing hematopoietic stem cell tran…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) [Phase 2]
Phase 2 trial of a cytomegalovirus vaccine for donors and recipients undergoing allogeneic hematopoietic cell transplantation has completed,…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL [Phase 2]
Phase 2 clinical trial evaluating nivolumab combined with ifosfamide, carboplatin, and etoposide as second-line therapy for recurrent or ref…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"
This Clinical Trial Update reports results from a Special Drug Use Surveillance study of Brentuximab Vedotin IV in relapsed or refractory CD…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas [Phase 2]
Phase 2 trial evaluating brentuximab vedotin in relapsed or refractory EBV-positive, CD30-positive lymphomas; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin
A completed study update based on a Spanish medical-record review of adults with relapsed or refractory CD30+ malignancies who were re-treat…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating Brentuximab Vedotin versus the B-CAP regimen in older patients with newly diagnosed classical Hodgk…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluating the combination of romidepsin and oral azacitidine in relapsed/refractory lymphoid malignancies, wit…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"
A clinical trial update reports completion and posting of results for a drug use surveillance study of Brentuximab vedotin in untreated CD30…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Relationship Between Serum β2-Microglobulin and Infiltration of CD8+ in the Tumor Tissue of Hodgkin's Lymphoma Patients
This completed clinical trial evaluated whether serum beta-2 microglobulin levels correlate with CD8+ T-cell infiltration in Hodgkin lymphom…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies [Phase 1]
Tinostamustine, a first-in-class alkylating HDAC inhibitor fusion molecule, completed its Phase 1 study in relapsed/refractory hematologic m…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders [Phase 1]
Phase 1 trial update on T-allo10 for hematopoietic stem cell transplantation in various blood disorders; the NCT03198234 study sponsored by …
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers [NA]
This clinical trial update indicates the study evaluating cardiac rehabilitation for patients receiving radiation therapy for thoracic cance…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial of temsirolimus for relapsed/refractory Hodgkin lymphoma was terminated; the update does not provide trial results.
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) [Phase 2]
Phase 2 study results of Brentuximab Vedotin in Hodgkin lymphoma and CD30-expressing peripheral T-cell lymphoma have been completed. The res…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma [Phase 3]
A Phase 3 clinical trial update evaluating Fludeoxyglucose F-18 PET/CT imaging to assess chemotherapy response in newly diagnosed Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) [Phase 2]
Phase 2 pediatric trial of Genistein for various cancers was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers [Phase 2]
A Phase 2 clinical trial update on haploidentical stem cell transplantation for multiple hematologic cancers, with the study status reported…
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: A Study of Anti-PD-1 AK105 in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma [Phase 1, Phase 2]
Clinical trial update for AK105 (anti-PD-1) in relapsed or refractory classic Hodgkin lymphoma completed phase 1/2.
-
CLINICAL_TRIALS trial_result · 2024-03-28Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial assessing camidanlumab tesirine (ADCT-301) for relapsed or refractory Hodgkin lymphoma has completed with results pos…